CervoMed Inc.

Cervomed Inc.

Biotechnology • Healthcare • Boston, MA, United States • CRVO (NCM)

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

617 744 4400 20 Park Plaza, Boston, MA 02116, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Gregoire buys $40k of CervoMed (CRVO) stock - Investing.com
Investing.com • Nov 13
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference - Yahoo Finance
Yahoo Finance • Nov 24
$CRVO stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitative • Dec 2
(CRVO) Risk Channels and Responsive Allocation - Stock Traders Daily
Stock Traders Daily • Dec 27
CervoMed on cusp of pivotal trial for dementia drug after tumultuous year - FirstWord Pharma
FirstWord Pharma • Dec 4

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has CervoMed Inc. had layoffs?
No layoff events have been recorded for CervoMed Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CervoMed Inc. have?
CervoMed Inc. has approximately 15 employees.
What industry is CervoMed Inc. in?
CervoMed Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CervoMed Inc. a publicly traded company?
Yes, CervoMed Inc. is publicly traded under the ticker symbol CRVO on the NCM. The company has a market capitalization of approximately $0.07 billion.
Where is CervoMed Inc. headquartered?
CervoMed Inc. is headquartered in Boston, MA, United States at 20 Park Plaza, Boston, MA 02116, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.